Piperacillin/tazobactam Induced Myelosuppression
Open Access
- 1 January 2009
- journal article
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 1 (1) , 53-5
Abstract
Neutropenia, secondary to immune destruction or maturation arrest, is the most commonly described adverse haematological effect of beta-lactam antibiotics. We describe a case of reversible pancytopenia, with evidence of hypocellular marrow, after a prolonged course of piperacillin/tazobactam for 26 days. Piperacillin; Tazobactam; Myelosuppression; Neutropenia.Keywords
This publication has 7 references indexed in Scilit:
- Systematic Review of Piperacillin-Induced NeutropeniaDrug Safety, 2007
- Incidence of Neutropenia during Treatment of Bone-Related Infections with Piperacillin-TazobactamClinical Infectious Diseases, 2003
- Piperacillin induced bone marrow suppression: a case reportBMC Clinical Pharmacology, 2003
- Isolated Severe Thrombocytopenia and Bleeding Caused by PiperacillinScandinavian Journal of Infectious Diseases, 1992
- Drug‐induced agranulocytosis: prognostic factors in a series of 168 episodesBritish Journal of Haematology, 1991
- Piperacillin-Induced Anemia and LeukopeniaSouthern Medical Journal, 1986
- Piperacillin Therapy for Pseudomonas InfectionsSouthern Medical Journal, 1983